Aligos Therapeutics, Inc. (ALGS)
2.15
-0.42
(-16.34%)
USD |
NASDAQ |
Nov 11, 16:00
2.09
-0.06
(-2.79%)
After-Hours: 19:59
Aligos Therapeutics Total Liabilities (Quarterly) : 35.88M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 35.88M |
| June 30, 2026 | 34.44M |
| March 31, 2026 | 32.77M |
| December 31, 2025 | 36.04M |
| September 30, 2025 | 37.93M |
| June 30, 2025 | 32.84M |
| March 31, 2025 | 34.25M |
| December 31, 2024 | 100.82M |
| September 30, 2024 | 38.33M |
| June 30, 2024 | 41.58M |
| March 31, 2024 | 68.11M |
| December 31, 2023 | 61.82M |
| September 30, 2023 | 31.03M |
| Date | Value |
|---|---|
| June 30, 2023 | 36.50M |
| March 31, 2023 | 36.99M |
| December 31, 2022 | 45.96M |
| September 30, 2022 | 42.06M |
| June 30, 2022 | 45.54M |
| March 31, 2022 | 57.58M |
| December 31, 2021 | 54.41M |
| September 30, 2021 | 46.06M |
| June 30, 2021 | 42.99M |
| March 31, 2021 | 39.32M |
| December 31, 2020 | 48.93M |
| September 30, 2020 | 228.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 357.70M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 52.02M |
| BioCryst Pharmaceuticals, Inc. | 988.45M |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.19M |
| Shareholders Equity (Quarterly) | 11.31M |
| Debt to Equity Ratio | 1.052 |
| Current Ratio | 1.770 |
| Net Debt Paydown Yield | -2.86% |